|
Pharma Marketing News is the monthly newsletter of the Pharma Marketing Network. It is distributed FREE to registered subscribers via email and the Web. Editorial & Advisory Board We accept advertising relevant to the interests of our subscribers. For more information, see: Published by: VirSci Corporation PO Box 760 Newtown, PA 18940 215-504-4164 215-504-5739 (FAX) E-mail: infovirsci@virsci.com |
![]() Pharma Marketing News | Subscribe | Discussion Forums | Roundtable | Podcasts | Blog Daily News Briefs | Surveys | Resources/Links | Glossary | Case Studies | Reports Pharma Marketing Vendor Directory | Conference Calendar | Pharma Jobs Advertising Information | FAQs | About Us | Privacy Policy
John Mack, MS, MPhil, Publisher & Editor President, VirSci Corporation Email: johnmack@virsci.com P: 215-504-4164 F: 215-504-5739
Mr. Mack is currently a principal consultant with VirSci Corporation, where he provides global pharmaceutical and health care industry clients with marketing communications, competitive market intelligence, and privacy/security consulting services. Previously, Mr. Mack was a consultant in the Life Sciences Practice at Answerthink, where he managed projects such as pharmaceutical DTC and physician web site development, privacy policy assessments, and HIPAA awareness workshops for healthcare providers. Mr. Mack also created and managed PharmInfoNet, a privately owned "Top 20 Health Site" focused on drug information content and databases for physicians and pharmacists. In 1999, he sold this web site to Mediconsult and became their Director of Drug Information. Mr. Mack often provides expert testimony and advice regarding HIPAA and privacy issues and he is a prolific author and speaker in these and other topic areas (see Publications and Presentations). As one of the leading authorities on standards for quality and privacy of health information on the Net, Mr. Mack is quoted often in the media (including the Wall Street Journal, USA Today, etc.), has lectured extensively, and is a member of numerous e-health related advisory boards and committees. More Information Return to top... Harry Sweeney, Advisory Board Member Chairman & CEO, Dorland Global Health Communications Email: HSweeney@dorland.com P: 215-625-0111 F: 215-625-0554 Harry Sweeney's career spans 40 years and includes a wide range of experience in pharmaceuticals, medical devices and diagnostics, distribution channels and healthcare institutional promotion. He has been a sales rep, a writer, a creative director, and the cofounder of a health communications agency that has established firm roots and credentials in an ever-changing field. Today, Harry provides business counsel, strategic marketing advice, and creative campaign planning for Dorland clients and also oversees the business management of the agency as its CEO. Always striving to better serve the agency's clients, Harry is passionate about keeping Dorland on the cutting edge of today's constantly evolving communications technology. Harry is a past president of the Healthcare Marketing Communications Council and has served in a variety of offices in HMCC and its predecessor, the Pharmaceutical Advertising Council. He has been an active member of the American Association of Advertising Agencies (Four As) for 25 years, serving as Chairman of the Philadelphia Council, and cofounder and Chairman of the Medical Advertising Committee. He presently serves as a member of the AAAA Government Relations Committee and its political action committee, AdPac. Harry also is a founder and Board member of the Coalition for Healthcare Communications and the Medical Advertising Hall of Fame. Harry writes, lectures, and speaks regularly to health marketers on communications and health policy topics, both domestically and abroad. He has testified at government hearings and has met with elected officials and regulatory personnel to discuss and resolve health communications policy issues. Harry holds two degrees: a BS in biology from Villanova University, and a JD from New York University School of Law. Return to top... Richard Vanderveer, PhD, Advisory Board Member Chairman & CEO, V2 GfK Email: rbvanderveer@v2gfk.com P: (215) 283-3200 F: (215) 283-3201
He has created and run three companies. His former companies include The Vanderveer Group (now TVG) and Physician Micromarketing, Inc. V2 is now Dr. Vanderveer's only company, which he has built into the leading pharmaceutical marketing research firm in the United States. Return to top... |
|